Proteinkinase Inhibitors

24.03.2022

Englisch

9783030681821

Springer International Publishing

Topics in Medicinal Chemistry

Nein

256

1

Broschiert

Stefan Laufer is a Professor of Pharmaceutical/Medicinal Chemistry at Tuebingen University, Germany, and he had previously worked for 10 years in the Pharmaceutical Industry. His research interests are anti-inflammatory and cancer drug discovery with various eicosanoid (COX-1,2,3, LOXs, mPGES1, cPLA2) and protein kinase targets (p38, JAKs, JNKs, CK1d, mtEGRFs). Three compounds from his lab entered clinical development phases. Dr. Laufer chairs the ICEPHA (Interfaculty Center for Pharmacogenomics and Drug Research) and TüCADD, Tuebingen Center for Academic Drug Discovery. As part of this work, a proprietary kinase inhibitor collection is established (TüKIC, 10.000 cpds). He authored more than 500 publications, 14 books/bookchapters, and is inventor in 42 patent families.

ProteinKinase, Receptor Tyrosine Kinases, EGFR, VEGFR, PDGFR, Protein Kinase Inhibitors, Topology of Proteinkinases, c-met, MAP-Kinases

PNB - Medizinische Chemie, Pharmazeutische Chemie PSB - Biochemie PNN - Organische Chemie

235 mm

15.5 cm